Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect

NCT03825510 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Crozer-Keystone Health System

Collaborators